Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351 (COVID-19)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05583357 |
|
Recruitment Status :
Active, not recruiting
First Posted : October 17, 2022
Last Update Posted : October 19, 2022
|
Sponsor:
Livzon Pharmaceutical Group Inc.
Information provided by (Responsible Party):
Livzon Pharmaceutical Group Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | September 13, 2022 |
| Estimated Study Completion Date : | August 10, 2023 |